MY195821A - Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers - Google Patents
Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other CancersInfo
- Publication number
- MY195821A MY195821A MYPI2019004578A MYPI2019004578A MY195821A MY 195821 A MY195821 A MY 195821A MY PI2019004578 A MYPI2019004578 A MY PI2019004578A MY PI2019004578 A MYPI2019004578 A MY PI2019004578A MY 195821 A MY195821 A MY 195821A
- Authority
- MY
- Malaysia
- Prior art keywords
- peptides
- cells
- tumor
- present
- relates
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 title 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 title 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 230000005975 antitumor immune response Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor- associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules. In particular, the present invention relates to several novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses or as targets for the development of pharmaceutically / immunologically active compounds and cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY195821A true MY195821A (en) | 2023-02-22 |
Family
ID=87569450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019004578A MY195821A (en) | 2019-08-08 | 2019-08-08 | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY195821A (en) |
-
2019
- 2019-08-08 MY MYPI2019004578A patent/MY195821A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3545965A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MY200985A (en) | Peptides and Combination of Peptides Of Non-Canonical Origin for use in Immunotherapy Against Different Types Of Cancers | |
| PH12019501377A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| PH12021550205A1 (en) | Immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methods | |
| PH12019502308A1 (en) | Peptides and combination thereof for use in the immunotherapy against cancers | |
| PH12021550346A1 (en) | B*44 restricted peptides for use in immunotherapy against cancers and related methods | |
| PH12020500051A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers | |
| PH12021550581A1 (en) | Immunotherapy with a*01 restricted peptides and combination of peptides against cancers and related methods | |
| PH12018502159A1 (en) | Immunotheraphy against melanoma and other cancers | |
| PH12020552013A1 (en) | A*03 restricted peptides for use in immunotherapy against cancers and related methods | |
| PH12020551958A1 (en) | Peptides for use in immunotherapy against cancers | |
| PH12019502300A1 (en) | Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers | |
| PH12021551460A1 (en) | Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods | |
| MX2020011787A (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers. | |
| PH12018502108A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers | |
| MY195821A (en) | Novel Peptides and Combination of Peptides for use in Immunotherapy Against Hepatocellular Carcinoma (Hcc) and other Cancers | |
| PH12018501639A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers | |
| NZ770913A (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MY197679A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| MY197794A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| MY197301A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| MY196396A (en) | Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers | |
| MY196395A (en) | Novel Peptides and Combination of Peptides and Scaffolds Thereof For use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers | |
| MY196399A (en) | Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers | |
| MY196687A (en) | Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers |